Polypills and 3D Printing: The Next Frontier of Personalized Medicine Read More @ https://www.techdogs.com/td-articles/techno-trends/top-pharmaceutical-technology-trends In 2026, the pharmaceutical industry is defined by Bio-Digital Integration, where Generative AI is used for de novo drug design and decentralized manufacturing allows for 3D-printed personalized medicine at the point of care. The rise of Digital Therapeutics (DTx) and blockchain-verified supply chains ensures that treatments are both hyper-personalized and securely tracked from lab to patient. This shift toward autonomous laboratories and predictive modeling is significantly reducing R&D timelines while improving patient outcomes through real-time biofeedback.